NCT00269022View on ClinicalTrials.gov

Use Of SB-705498 In The Acute Treatment Of Migraine

PHASE2CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

January 31, 2006

Conditions

Migraine, Acute

Interventions

DRUG

SB-705498

Trial Locations (4)

2031

GSK Investigational Site, Randwick

M1L 4S4

GSK Investigational Site, Toronto

2333 ZA

GSK Investigational Site, Leiden

CB2 2GG

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00269022 - Use Of SB-705498 In The Acute Treatment Of Migraine | Biotech Hunter | Biotech Hunter